European Journal of Molecular & Clinical Medicine

Abstract

Background:Diabetes in Pregnancy Study Group India (DIPSI) and International
Association of Diabetes and Pregnancy Study Groups (IADPSG) recommendations are
general diagnostic criteria utilized in our country for determining gestational diabetes
mellitus (GDM). To diagnosis GDM, the IADPSG following Hyperglycaemia and Adverse
Pregnancy Outcome (HAPO) recommends fasting plasma glucose (FPG) of 92 mg/dL, 1-h
PG of 180 mg/dL, or 2-h PG of 153 mg/dL.
Aims:To compare DIPSI recommended GTT and IADPSG-2 phase strategy in terms of
efficacy for diagnosing GDM.
Materials and methods:The study was undertaken on antenatal women in the Out Patient
Department of our hospital. It was done to compare the efficacy of DIPSI recommended GTT
and IADPSG2-phasestrategyin diagnosing GDM and also to study the neonates of the two
groups in terms birth weight, presence of neonatal hyperbilirubinemia and presence of any
respiratory distress.
Results:The data from 70 women in groups A and B was analysed. There is no statistically
significant difference in the demographic distribution of the study groups. The number of
GDM cases detected by the two diagnostic criteria did not differ significantly. When
comparing the two groups, birth weight, respiratory distress, and neonatal hyperbilirubinemia
are all negligible. When comparing groups, the type of labour and delivery are unimportant.
In both study groups, there is no significant difference in the frequency of GDM patients who
require either MNT or insulin +MNT.
Conclusions:We conclude that application of DIPSIGTT is comparable to the new IADPSG
guidelines recommended by ADA in the diagnosis of GDM Even those who came under lowrisk
category for developing GDM according to ADA were found to develop GDM in the
study population in both the groups.